Active-ingredient Dossier
Fulvestrant
Active-ingredient Dossier for Fulvestrant (selective estrogen receptor degrader). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: FULVESTRANT
- Brand: FULVESTRANT
- Brand: FULVESTRANT
- Brand: FULVESTRANT
- Brand: FULVESTRANT-AFT
- Brand: EUG-FULVESTRANT
- Therapeutic area: Oncology
What is Fulvestrant Fulvestrant is a selective estrogen receptor degrader .
Australian brands containing Fulvestrant
— FULVESTRANT — FULVESTRANT-AFT — EUG-FULVESTRANT
Therapeutic areas
Fulvestrant is registered in oncology, with seven brands containing the ingredient on the ARTG .
Sponsor landscape
Fulvestrant is marketed by six sponsors: Eugia Pharma, Southern XP IP, Accord Healthcare, Interpharma, Sandoz, and AFT Pharmaceuticals .
PBS and regulatory activity
One brand containing fulvestrant has PBS-listed items, with the latest PBS schedule date of 1 May 2026 . The latest PBAC outcome is from 1 November 2022, with two brands holding PBAC outcomes on record .